Is Marine Products Corp. (MPX) A Good Stock To Buy?

Now, some big names have jumped into Marine Products Corp. (NYSE:MPX) headfirst. Among them, Coe Capital Management created the largest position in Marine Products Corp. (NYSE:MPX), having $0.2 million invested in the company at the end of the quarter.

Let’s go over hedge fund activity in other stocks similar to Marine Products Corp. (NYSE:MPX). We will take a look at Model N Inc (NYSE:MODN), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Tandem Diabetes Care Inc (NASDAQ:TNDM), and Cell Therapeutics Inc (NASDAQ:CTIC). This group of stocks’ market values are similar to MPX’s market value.

As you can see these stocks had an average of 12.25 hedge funds with bullish positions and the average amount invested in these stocks was $39 million, while in MPX, hedge funds amassed stakes with an aggregate value of $17 million. Orexigen Therapeutics, Inc. (NASDAQ:OREX) is the most popular stock in this table. On the other hand, Tandem Diabetes Care Inc (NASDAQ:TNDM) is the least popular one with only 8 bullish hedge fund positions. Compared to these stocks Marine Products Corp. (NYSE:MPX) is even less popular than TNDM. Considering that hedge funds aren’t fond of this stock in relation to other companies analyzed in this article, it may be a good idea to analyze it in detail and understand why the smart money isn’t behind this stock. This isn’t necessarily bad news. Although it is possible that hedge funds may think the stock is overpriced and view the stock as a short candidate, they may not be very familiar with the bullish thesis. In either case more research is required.